BRIEF-Cellectis is granted patent for CRISPR use in T-cells – Reuters
|
BRIEF-Cellectis is granted patent for CRISPR use in T-cells
Reuters ANNOUNCED ON MONDAY ABOUT THE GRANT BY THE EUROPEAN PATENT OFFICE OF PATENT NO. EP3004337 FOR THE INVENTION OF USING RNA-GUIDED ENDONUCLEASES, SUCH AS CAS9 OR CPF1 FOR THE GENETIC ENGINEERING OF … |
